Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
Canadian Psychiatric Association 2006 Annual Conference
ADHD from Childhood to Adulthood: Clinical Viewpoints
Toronto, Ontario / November 9-12, 2006
Attention deficit/hyperactivity disorder (ADHD) is not just a North American phenomenon but is seen virtually everywhere in the world, stated Dr. Lily Hechtman, Professor of Psychiatry and Pediatrics, McGill University, Montreal, Quebec....
19th Congress of the European College of Neuropsychopharmacology
New Perspectives on Managing Patients with Schizophrenia
Paris, France / September 16-20, 2006
Paris - Improved subjective well-being and quality of life are important considerations in treatment outcomes for patients with schizophrenia. These outcomes are highly dependent on patients’ compliance with their antipsychotic medication....
19th Congress of the European College of Neuropsychopharmacology
Sustainable Remission: An Achievable Goal in Schizophrenia
Paris, France / September 16-20, 2006
Paris - The availability of atypical antipsychotic agents has improved treatment outcomes in patients with schizophrenia. Sustainable remission and even recovery are now considered reasonable goals for this patient group. Effective...
13th World Conference on Tobacco or Health
Combining Behavioural Counselling with Pharmacological Therapy: A Viable Formula for Smoking Cessation
Washington, DC / July 12-15, 2006
Washington, DC - Double-blind controlled trials have demonstrated that the relative specificity of pharmacologic therapies directed at central mediators of tobacco addiction appear to promote longer remission from smoking, according to...
159th Annual Meeting of the American Psychiatric Association
Addressing Quality of Life in Pediatric and Adult ADHD Patient Populations
Toronto, Ontario / May 20-25, 2006
A wide range of options in the attention-deficit hyperactivity disorder (ADHD) armamentarium, including mixed amphetamine salts (MAS) compounds, methylphenidate (MPH) and atomoxetine, are transforming the quality of life for children,...
61st Annual Meeting of the Society of Biological Psychiatry
Reassessing Delayed Onset of Action in Depression Therapy
Toronto, Ontario / May 18-20, 2006
Toronto - Psychiatrists have long believed that onset of antidepressant action does not occur for three to six weeks from initiation of therapy. New evidence suggests that this view is incorrect and that if patients are going to respond,...